
AYURF
Healthcare · Drug Manufacturers - Specialty & Generic · $58,411 market cap
$0.00030.00 (0.0%)Nov 13, 9:30 AM EST
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Sep 30, 2022
EPS trend, 90 days to now · 30-day revisions 0 up, 0 down
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| May 26, 2025 | Before the open | — | -0.00 | — |
| Feb 26, 2025 | Before the open | — | -0.00 | — |
| Nov 27, 2024 | Before the open | — | -0.00 | — |
| May 27, 2024 | Before the open | — | -0.00 | — |
| Feb 28, 2024 | Before the open | — | -0.00 | — |
| Nov 29, 2023 | Before the open | — | -0.00 | — |
| May 29, 2023 | Before the open | — | -0.00 | — |
| Feb 27, 2023 | Before the open | — | -0.00 | — |
| Nov 29, 2022 | Before the open | — | -0.01 | — |
| May 26, 2022 | Before the open | — | -0.00 | — |
| Feb 22, 2022 | Before the open | — | -0.00 | — |
| Nov 29, 2021 | Before the open | — | 0.00 | — |
| May 18, 2021 | After the close | — | -0.02 | — |
Ayurcann Holdings Corp. provides post-harvest outsourcing solutions to licensed cannabis producers in Canada. The company offers extraction, processing, and co-manufacturing of pharma grade cannabis to produce various derivative cannabis products in the medical and recreational markets. It also manufactures and distributes cannabis products. The company sells product under the Fuego, H&S, and XPLOR brand names.…